Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1979 1
1989 1
1990 1
1992 2
1994 1
1996 3
1997 4
1998 3
1999 6
2000 17
2001 10
2002 16
2003 18
2004 21
2005 34
2006 34
2007 39
2008 53
2009 65
2010 65
2011 71
2012 44
2013 27
2014 21
2015 21
2016 18
2017 16
2018 14
2019 6
2020 22
2021 2
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 19897698

617 results
Results by year
Filters applied: . Clear all
Page 1
Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?
Ong HT. Ong HT. J Am Board Fam Med. 2009 Nov-Dec;22(6):686-97. doi: 10.3122/jabfm.2009.06.090094. J Am Board Fam Med. 2009. PMID: 19897698 Free article. Review.
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR. Weir MR. Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019. Clin Ther. 2007. PMID: 18035185 Review.
Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
[No authors listed] [No authors listed] Prescrire Int. 2005 Oct;14(79):180-6. Prescrire Int. 2005. PMID: 16285075
Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.
Kolasinska-Malkowska K, Filipiak KJ, Gwizdala A, Tykarski A. Kolasinska-Malkowska K, et al. Expert Rev Cardiovasc Ther. 2008 Jun;6(5):759-71. doi: 10.1586/14779072.6.5.759. Expert Rev Cardiovasc Ther. 2008. PMID: 18510491 Review.
Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: where do we stand now?
Böhm M. Böhm M. Am J Cardiol. 2007 Aug 6;100(3A):38J-44J. doi: 10.1016/j.amjcard.2007.05.013. Epub 2007 May 25. Am J Cardiol. 2007. PMID: 17666197 Review.
Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH. Leenen FH. Can J Cardiol. 2004 Aug;20 Suppl B:77B-82B. Can J Cardiol. 2004. PMID: 15309209 Review.
Current recommendations for the treatment of hypertension: are they still valid?
Moser M. Moser M. J Hypertens Suppl. 2002 Feb;20(1):S3-10. J Hypertens Suppl. 2002. PMID: 11996197
The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, Køber L, Van de Werf F, Califf R, Pfeffer M. McMurray J, et al. J Am Coll Cardiol. 2006 Feb 21;47(4):726-33. doi: 10.1016/j.jacc.2005.09.055. Epub 2006 Jan 26. J Am Coll Cardiol. 2006. PMID: 16487836 Free article.
617 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback